Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,650.00p
   
  • Change Today:
      24.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 2,234.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 139,772
  • Market Cap: £1,743.00m
  • RiskGrade: 128

Geographical - by origin

  30-Jun-2130-Jun-2030-Jun-1930-Jun-1530-Jun-14
Revenue
Asia101.5018%70.8013%44.209%41.4010%46.5012%
Europen/an/an/an/an/an/a116.9029%121.8033%
Latin America83.8015%81.8015%81.1017%59.0015%50.2013%
North America214.7037%226.4041%211.8043%181.2045%153.7041%
Rest of Europe, Middle East, Russia and Africa82.1014%78.0014%67.7014%n/an/an/an/a
UK92.2016%94.4017%83.7017%n/an/an/an/a
Total 574.30100% 551.40100% 488.50100% 398.50100% 372.20100% 
 
Profit Before Tax
Unanalysed55.80100%46.30100%9.90100%57.80100%38.20100%
Total 55.80100% 46.30100% 9.90100% 57.80100% 38.20100% 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  30-Jun-2130-Jun-2030-Jun-1930-Jun-1530-Jun-14
Revenue
Dairy & beefn/an/an/an/an/an/a183.4046%171.8046%
Genus ABS250.1044%237.6043%222.6046%n/an/an/an/a
Genus PIC315.6055%298.8054%253.7052%n/an/an/an/a
Porcine Geneticsn/an/an/an/an/an/a201.3051%184.9050%
Research & developmentn/an/an/an/an/an/a13.803%15.504%
Research and Development8.601%15.003%12.202%n/an/an/an/a
Total 574.30100% 551.40100% 488.50100% 398.50100% 372.20100% 
 
Profit Before Tax
Dairy & beefn/an/an/an/an/an/a14.50n/a15.70n/a
Genus ABS36.40n/a32.50n/a29.90n/an/an/an/an/a
Genus PIC122.90n/a113.30n/a93.10n/an/an/an/an/a
Porcine Geneticsn/an/an/an/an/an/a52.40n/a43.10n/a
Research & developmentn/an/an/an/an/an/a(15.70)n/a(14.00)n/a
Research and Development(62.40)n/a(64.90)n/a(54.40)n/an/an/an/an/a
Unanalysed(41.10)n/a(34.60)n/a(58.70)n/a6.60n/a(6.60)n/a
Total 55.80n/a 46.30n/a 9.90n/a 57.80n/a 38.20n/a 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page